Safety, pharmacokinetics, and pharmacodynamics results from a phase I trial of BAY 86-9766 (RDEA119), a MEK inhibitor, in patients with advanced cancer.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 3007-3007 ◽  
Author(s):  
L. Gore ◽  
K. Lewis ◽  
D. D. Von Hoff ◽  
G. J. Weiss ◽  
R. K. Ramanathan ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Phase I Trial ◽  
Mek Inhibitor ◽  
Pharmacokinetics And Pharmacodynamics

Abstract CT019: A phase I trial of the combination of the dual RAF-MEK inhibitor VS-6766 and the FAK inhibitor defactinib: Evaluation of efficacy in KRAS mutated NSCLC

2021 ◽  
Author(s):  
Matthew G. Krebs ◽  
Rajiv Shinde ◽  
Rozana Abdul Rahman ◽  
Rafael Grochot ◽  
Martin Little ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Mek Inhibitor

Phase I trial of the novel platinum analog ZD0473 in combination with gemcitabine in patients with advanced cancer

2001 ◽  
Vol 37 ◽  
pp. S71
Author(s):  
P. O'Dwyer ◽  
J. Stevenson ◽  
M. Redlinger ◽  
W. Sun ◽  
B. Giantonio ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Phase I Trial ◽  
The Novel

scholarly journals Phase I Trial of Cixutumumab Combined with Temsirolimus in Patients with Advanced Cancer

2011 ◽  
Vol 17 (18) ◽  
pp. 6052-6060 ◽  
Author(s):  
Aung Naing ◽  
Razelle Kurzrock ◽  
Angelika Burger ◽  
Sachin Gupta ◽  
Xiudong Lei ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Phase I Trial

A phase I trial of Depsipeptide (FR901228) in patients with advanced cancer

2002 ◽  
Vol 2 (6) ◽  
pp. 325-332 ◽  
Author(s):  
John L. Marshall ◽  
Naiyer Rizvi ◽  
John Kauh ◽  
William Dahut ◽  
Manuela Figuera ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Phase I Trial

Phase I trial of oral topotecan with intravenous carboplatin in patients with advanced cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3184-3184
Author(s):  
J. R. Ackler ◽  
A. Desai ◽  
J. C. Leighton ◽  
W. J. Tester
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Phase I Trial ◽  
Oral Topotecan

A phase I trial of 17-allylamino-geldanamycin (17AAG) in patients with advanced cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3030-3030 ◽  
Author(s):  
C. Erlichman ◽  
D. Toft ◽  
J. Reid ◽  
M. Goetz ◽  
M. Ames ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Phase I Trial

Phase I trial of patupilone plus carboplatin in patients with advanced cancer

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 5087-5087 ◽  
Author(s):  
M. Gore ◽  
S. Kaye ◽  
A. Oza ◽  
C. Keyzor ◽  
L. Pyle ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Phase I Trial

Phase I trial of personalized peptide vaccine for HLA-A24 positive patients with advanced cancer

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 3079-3079
Author(s):  
M. Terasaki ◽  
M. Noguchi ◽  
S. Naito ◽  
H. Uemura ◽  
H. Akaza ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Phase I Trial ◽  
Peptide Vaccine ◽  
Personalized Peptide Vaccine
Sign in / Sign up

Export Citation Format

Share Document